Deka Bank Deutsche Girozentrale Biogen Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Biogen Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 108,721 shares of BIIB stock, worth $17.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

108,721

Previous 106,968 1.64%

Holding current value

$17.4 Million

Previous $24.4 Million 13.14%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$189.07 - $236.8 $331,439 - $415,110	1,753 Added 1.64%	108,721 $21.2 Million
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $424,859 - $527,885	-2,230 Reduced 2.04%	106,968 $24.4 Million
Q1 2024 Apr 24, 2024	SELL	$212.02 - $267.71 $36.9 Million - $46.6 Million	-174,070 Reduced 61.45%	109,198 $23.5 Million
Q4 2023 Jan 24, 2024	SELL	$222.59 - $267.94 $191,649 - $230,696	-861 Reduced 0.3%	283,268 $73.4 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $11.5 Million - $13 Million	45,530 Added 19.08%	284,129 $72.9 Million
Q2 2023 Jul 25, 2023	BUY	$275.25 - $318.06 $1.19 Million - $1.37 Million	4,317 Added 1.84%	238,599 $67.4 Million
Q1 2023 Apr 24, 2023	BUY	$256.56 - $292.34 $21.5 Million - $24.5 Million	83,922 Added 55.81%	234,282 $64.2 Million
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $622,012 - $755,758	-2,464 Reduced 1.61%	150,360 $41.2 Million
Q3 2022 Nov 02, 2022	SELL	$194.69 - $268.46 $3.94 Million - $5.43 Million	-20,227 Reduced 11.69%	152,824 $40.3 Million
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $655,077 - $779,008	-3,493 Reduced 1.98%	173,051 $35.2 Million
Q1 2022 Apr 28, 2022	SELL	$193.77 - $244.14 $2.32 Million - $2.93 Million	-11,983 Reduced 6.36%	176,544 $37.4 Million
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $14.3 Million - $18.4 Million	63,926 Added 51.3%	188,527 $46.5 Million
Q3 2021 Oct 22, 2021	SELL	$282.99 - $369.05 $19.1 Million - $24.9 Million	-67,344 Reduced 35.09%	124,601 $35.5 Million
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $5.96 Million - $9.54 Million	-22,998 Reduced 10.7%	191,945 $66 Million
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $143,826 - $168,500	592 Added 0.28%	214,943 $59.3 Million
Q4 2020 Mar 12, 2021	SELL	$236.26 - $355.63 $5.17 Million - $7.79 Million	-21,903 Reduced 9.27%	214,351 $52.4 Million
Q3 2020 Oct 29, 2020	BUY	$264.77 - $305.71 $43.2 Million - $49.9 Million	163,257 Added 223.65%	236,254 $66 Million
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $2.17 Million - $2.88 Million	8,396 Added 13.0%	72,997 $18.9 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $2.42 Million - $3.07 Million	-9,011 Reduced 12.24%	64,601 $20.5 Million
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $14.1 Million - $19.6 Million	-64,299 Reduced 46.62%	73,612 $22 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $12.5 Million - $14 Million	-57,361 Reduced 29.37%	137,911 $31.9 Million
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $3.18 Million - $3.51 Million	14,519 Added 8.03%	195,272 $46.9 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $2.59 Million - $4.06 Million	11,974 Added 7.09%	180,753 $64.1 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $3.33 Million - $4.22 Million	-11,974 Reduced 6.62%	168,779 $49.9 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $2.97 Million - $3.89 Million	-10,133 Reduced 5.31%	180,753 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $11.7 Million - $13.9 Million	-45,379 Reduced 19.21%	190,886 $55.3 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $4.92 Million - $6.96 Million	18,913 Added 8.7%	236,265 $64.5 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $61,528 - $68,916	200 Added 0.09%	217,352 $64.1 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $61.1 Million - $71.6 Million	217,152	217,152 $64 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Biogen Inc. Transaction History